Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Zepbound vs Mounjaro: Head-to-Head Efficacy Comparison At a glance Active ingredient / tirzepatide (dual GIP/GLP-1 receptor agonist) in both products Manufacturer / Eli Lilly for both Zepbound and Mounjaro Zepbound FDA approval / November 2023 for chronic weight management Mounjaro FDA approval / May 2022 for type 2 diabetes (T2D) SURMOUNT-1 weight loss / 20.9% mean body-weight reduction at 72 weeks (15 mg dose) SURPASS-2 A1C reduction / up to 2.3 percentage points vs 1.86 for semaglutide 1 mg Dose range / 2.5 mg to 15 mg weekly subcutaneous injection for both brands Head-to-head trial / none exists
What Medicines Can You Not Take with Mounjaro: Complete Safety Guide What medicines can you not take with Mounjaro? comes down to anything that increases
Improved plasma arginine and nitric oxide levels when combined Once again, a combination of citrulline and arginine was significantly better than either citrulline or arginine, and vastly superior to placebo
A1C is especially useful for evaluating long-term glycemic control
Sahebari M, Rezaieyazdi Z, Khodashahi M
After reconstitution, follow your institutional SOP for temperature, light exposure, and working-solution stability
